feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: FDA Panel Review For Alkermes, Axovant Gets Rare Pediatric Disease Designation, 2 IPOs",https://www.benzinga.com/general/biotech/20/10/17849156/the-daily-biotech-pulse-fda-panel-review-for-alkermes-axovant-gets-rare-pediatric-disease-designa,https://j.mp/30QnJsH
